Haleon (XTER:H6D0) Other Current Payables : €0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Other Current Payables?

Haleon's Other Current Payables for the quarter that ended in Mar. 2024 was €0 Mil.

Haleon's quarterly Other Current Payables increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€1,435 Mil) but then declined from Dec. 2023 (€1,435 Mil) to Mar. 2024 (€0 Mil).

Haleon's annual Other Current Payables declined from Dec. 2021 (€1,589 Mil) to Dec. 2022 (€1,535 Mil) and declined from Dec. 2022 (€1,535 Mil) to Dec. 2023 (€1,435 Mil).

Haleon Other Current Payables Historical Data

The historical data trend for Haleon's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Other Current Payables Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

1,608.91

1,278.30

1,588.76

1,535.01

1,434.70

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Payables	Get a 7-Day Free Trial									-	-	-	1,434.70	-

Haleon Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Haleon Other Current Payables Related Terms

Thank you for viewing the detailed overview of Haleon's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (XTER:H6D0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (XTER:H6D0) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN1:Mexico HLNl:UK HLN:UK

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Haleon (XTER:H6D0) Headlines

No Headlines